Payment overview · 2025
General Payments
$54.99
1 reported records · 1 companies
Healthcare provider profile · identity verified
Sameera Ali, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine|Geriatric Medicine · WORCESTER, MA · NPI 1760703409
Verified facts
What the public records show
CMS Open Payments records show Sameera Ali, M.D. received $54.99 in general payments during 2025 across 1 reported records.
Abbott Laboratories accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $54.99 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Long term medical supply or device loan | $54.99 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FREESTYLE COPILOT Normalized: freestyle copilot |
Device | Abbott Laboratories | $54.99 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 697 | 59 |
| Amlodipine Besylate | Amlodipine Besylate | 550 | 43 |
| Gabapentin | Gabapentin | 547 | 31 |
| Trazodone Hcl | Trazodone Hcl | 427 | 29 |
| Lisinopril | Lisinopril | 345 | 24 |
| Levothyroxine Sodium | Levothyroxine Sodium | 326 | 29 |
| Eliquis | Apixaban | 301 | 20 |
| Furosemide | Furosemide | 265 | 19 |
| Omeprazole | Omeprazole | 263 | 22 |
| Metformin Hcl | Metformin Hcl | 261 | 17 |
| Tamsulosin Hcl | Tamsulosin Hcl | 242 | 14 |
| Donepezil Hcl | Donepezil Hcl | 210 | 17 |
| Losartan Potassium | Losartan Potassium | 190 | 17 |
| Baclofen | Baclofen | 156 | 14 |
| Metoprolol Tartrate | Metoprolol Tartrate | 152 | suppressed |
| Metoprolol Succinate | Metoprolol Succinate | 150 | 21 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 125 | suppressed |
| Trulicity | Dulaglutide | 122 | suppressed |
| Olanzapine | Olanzapine | 120 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 119 | 18 |
| Famotidine | Famotidine | 105 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 99 | suppressed |
| Pantoprazole Sodium | Pantoprazole Sodium | 90 | 13 |
| Mirtazapine | Mirtazapine | 88 | 12 |
| Memantine Hcl | Memantine Hcl | 84 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 82 | suppressed |
| Levetiracetam | Levetiracetam | 81 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 80 | suppressed |
| Finasteride | Finasteride | 80 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 78 | 12 |
| Glipizide | Glipizide | 75 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 74 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 72 | suppressed |
| Atenolol | Atenolol | 70 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 70 | suppressed |
| Torsemide | Torsemide | 69 | suppressed |
| Latanoprost | Latanoprost | 68 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 66 | 22 |
| Potassium Chloride | Potassium Chloride | 64 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 62 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 60 | 18 |
| Xarelto | Rivaroxaban | 60 | suppressed |
| Topiramate | Topiramate | 56 | suppressed |
| Carvedilol | Carvedilol | 54 | suppressed |
| Repaglinide | Repaglinide | 52 | suppressed |
| Sucralfate | Sucralfate | 52 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 52 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 51 | suppressed |
| Risperidone | Risperidone | 50 | suppressed |
| Ezetimibe | Ezetimibe | 48 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 46 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 45 | suppressed |
| Chlorthalidone | Chlorthalidone | 43 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 42 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 42 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 37 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 36 | suppressed |
| Pregabalin | Pregabalin | 34 | suppressed |
| Spironolactone | Spironolactone | 34 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 32 | 13 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 31 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 31 | suppressed |
| Prednisone | Prednisone | 31 | suppressed |
| Simvastatin | Simvastatin | 29 | suppressed |
| Lacosamide | Lacosamide | 28 | suppressed |
| Lamotrigine | Lamotrigine | 28 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 27 | suppressed |
| Januvia | Sitagliptin Phosphate | 27 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 27 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 26 | 15 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 26 | suppressed |
| Glipizide Er | Glipizide | 25 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 23 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 23 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 23 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 23 | suppressed |
| Nystatin | Nystatin | 23 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 21 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 20 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 19 | suppressed |
| Nystop | Nystatin | 19 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 18 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 18 | suppressed |
| Entresto | Sacubitril/Valsartan | 18 | suppressed |
| Jardiance | Empagliflozin | 18 | suppressed |
| Retacrit | Epoetin Alfa-Epbx | 18 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 18 | 17 |
| Clonazepam | Clonazepam | 17 | suppressed |
| Myrbetriq | Mirabegron | 17 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 16 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 15 | 15 |
| Brimonidine Tartrate | Brimonidine Tartrate | 15 | suppressed |
| Fenofibrate | Fenofibrate | 15 | suppressed |
| Brilinta | Ticagrelor | 14 | suppressed |
| Bumetanide | Bumetanide | 14 | suppressed |
| Estradiol | Estradiol | 14 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 14 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 14 | suppressed |
| Fluconazole | Fluconazole | 14 | suppressed |
| Valsartan | Valsartan | 14 | suppressed |
| Bupropion Xl | Bupropion Hcl | 13 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 13 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 13 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 13 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Lorazepam | Lorazepam | 13 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 13 | suppressed |
| Rexulti | Brexpiprazole | 13 | suppressed |
| Timolol Maleate | Timolol Maleate | 13 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 12 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 12 | suppressed |
| Galantamine Er | Galantamine Hbr | 12 | suppressed |
| Lovastatin | Lovastatin | 12 | suppressed |
| Metolazone | Metolazone | 12 | suppressed |
| Minoxidil | Minoxidil | 12 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 12 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 12 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 12 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 11 | suppressed |
| Ketoconazole | Ketoconazole | 11 | suppressed |
| Lidocaine | Lidocaine | 11 | suppressed |
| Mupirocin | Mupirocin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $54.99 · 1 records | Abbott Laboratories | FREESTYLE COPILOT | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error